Rxcurve
HCPCS J3486 · per 10 MG

Ziprasidone mesylate

Products billed under this code include Geodon, Ziprasidone Mesylate.

Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J3486

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Geodon Viatris Specialty LLC 00049-3920-10 20 $118.80
Geodon A-S Medication Solutions 50090-4540-00 2 $11.88
Geodon Viatris Specialty LLC 58151-0137-81 20 $118.80
Ziprasidone Mesylate Dr. Reddy's Laboratories Inc. 43598-0061-58 20 $118.80
Ziprasidone Mesylate Dr. Reddy's Laboratories Inc. 43598-0848-58 20 $118.80
Ziprasidone Mesylate HF Acquisition Co. LLC, DBA HealthFirst 51662-1564-03 100 $594.00
Ziprasidone Mesylate Novadoz Pharmaceuticals LLC 72205-0205-07 20 $118.80
Ziprasidone Mesylate Fosun Pharma USA Inc. 72266-0160-10 20 $118.80
Ziprasidone Mesylate Fosun Pharma USA Inc. 72266-0160-42 20 $118.80

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $5.94 +$0.338 10 MG Ziprasidone mesylate v1, posted September 17, 2026
3Q26 $5.602 −$0.271 10 MG Ziprasidone mesylate v1, posted September 15, 2026
2Q26 $5.873 −$3.275 10 MG Ziprasidone mesylate v1, posted September 15, 2026
1Q26 $9.148 +$2.322 10 MG Ziprasidone mesylate v1, posted September 15, 2026
4Q25 $6.826 +$3.688 10 MG Ziprasidone mesylate v1, posted September 8, 2026
3Q25 $3.138 −$2.045 10 MG Ziprasidone mesylate v1, posted March 10, 2026
2Q25 $5.183 −$2.008 10 MG Ziprasidone mesylate v1, posted March 10, 2026
1Q25 $7.191 −$0.241 10 MG Ziprasidone mesylate v1, posted December 19, 2025
4Q24 $7.432 −$0.65 10 MG Ziprasidone mesylate v1, posted June 11, 2025
3Q24 $8.082 −$2.139 10 MG Ziprasidone mesylate v1, posted June 11, 2025
2Q24 $10.221 +$0.466 10 MG Ziprasidone mesylate v1, posted March 11, 2025
1Q24 $9.755 −$0.19 10 MG Ziprasidone mesylate v1, posted December 19, 2024
4Q23 $9.945 +$0.342 10 MG Ziprasidone mesylate v1, posted October 10, 2024
3Q23 $9.603 −$0.515 10 MG Ziprasidone mesylate v1, posted June 5, 2024
2Q23 $10.118 −$0.038 10 MG Ziprasidone mesylate v1, posted February 23, 2024
1Q23 $10.156 −$0.819 10 MG Ziprasidone mesylate v1, posted December 6, 2023
4Q22 $10.975 −$0.609 10 MG Ziprasidone mesylate v1, posted June 22, 2023
3Q22 $11.584 −$0.933 10 MG Ziprasidone mesylate v1, posted June 9, 2023
2Q22 $12.517 −$0.865 10 MG Ziprasidone mesylate v1, posted December 14, 2022
1Q22 $13.382 −$1.463 10 MG Ziprasidone mesylate v1, posted June 8, 2022
4Q21 $14.845 −$1.583 10 MG Ziprasidone mesylate v1, posted June 2, 2022
3Q21 $16.428 −$1.622 10 MG Ziprasidone mesylate v1, posted June 2, 2022
2Q21 $18.05 −$2.901 10 MG Ziprasidone mesylate v1, posted March 1, 2022
1Q21 $20.951 – 10 MG Ziprasidone mesylate v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files